Factors Associated With Severe Acute Esophagitis From Hyperfractionated Radiotherapy With Concurrent Chemotherapy for Limited-Stage Small-Cell Lung Cancer

International Journal of Radiation Oncology Biology Physics

Volumn 74, Issue 4, 2009, Pages 1108-1113

  Watkins, John M ^a   Wahlquist, Amy E ^b   Shirai, Keisuke ^a   Garrett Mayer, Elizabeth ^a,b   Aguero, Eric G ^a   Fortney, John A ^a   Sherman, Carol A ^a   Sharma, Anand K ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Computer assisted radiotherapy planning; esophagitis; Hyperfractionation; Radiation injuries; small cell lung cancer

Indexed keywords

COMPUTER-ASSISTED RADIOTHERAPY PLANNING; ESOPHAGITIS; HYPERFRACTIONATION; RADIATION INJURIES; SMALL-CELL LUNG CANCER;

BIOLOGICAL ORGANS; CHEMOTHERAPY; DOSIMETERS; DOSIMETRY; FLUORESCENT SCREENS; PLATINUM; RADIOTHERAPY; STATISTICS; TELEVISION PICTURE TUBES; TUMORS;

REGRESSION ANALYSIS;

CARBOPLATIN; CISPLATIN; ETOPOSIDE;

ACUTE DISEASE; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER RADIOTHERAPY; CHEMOTHERAPY; CLINICAL ARTICLE; COHORT ANALYSIS; CORRELATION ANALYSIS; DOSIMETRY; ESOPHAGITIS; HUMAN; INCIDENCE; LOGISTIC REGRESSION ANALYSIS; LUNG SMALL CELL CANCER; MALE; MULTIPLE CYCLE TREATMENT; MULTIPLE REGRESSION; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; RISK FACTOR; TUMOR VOLUME;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AREA UNDER CURVE; CARBOPLATIN; CISPLATIN; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; ESOPHAGITIS; ETOPOSIDE; FEMALE; HUMANS; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SMALL CELL LUNG CARCINOMA;

EID: 67649556653     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.09.013     Document Type: Article

References (19)

1. Turrisi A.T., Kim K., Blum R., et al. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. New Engl J Med 340 (1999) 265-271
2. Werner-Wasik M., Pequignot E., Leeper D., et al. Predictors of severe esophagitis include use of concurrent chemotherapy, but not the length of irradiated esophagus: A multivariate analysis of patients with lung cancer treated with non-operative therapy. Int J Radiat Oncol Biol Phys 48 (2000) 689-696
3. Singh A.K., Lockett M.A., and Bradley J.D. Predictors of radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 55 (2003) 337-341
4. Choi N.C., Herndon J.E., Rosenman J., et al. Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer. J Clin Oncol 16 (1998) 3528-3536
5. In: Bonate P., and Howard D. (Eds). Pharmacokinetics in drug development: clinical study design and analysis (2005), Springer Publishing Company, New York
6. Qiao W.-B., Zhao Zhao Y.-H., Zhao Y.-B., et al. Clinical and dosimetric factors of radiation-induced esophageal injury: Radiation-induced esophageal toxicity. World J Gastroenterol 11 (2005) 2626-2639
7. Belderbos J., Heemsbergen W., Hoogeman M., et al. Acute esophageal toxicity in non-small cell lung cancer patients after high dose conformal radiotherapy. Radiother Oncol 75 (2005) 157-164
8. Patel A.B., Edelman M.J., Kwok Y., et al. Predictors of acute esophagitis in patients with non-small-cell lung carcinoma treated with concurrent chemotherapy and hyperfractionated radiotherapy followed by surgery. Int J Radiat Oncol Biol Phys 60 (2004) 1106-1112
9. De Ruysscher D., Dehing C., Bremer R.-H., et al. Maximal neutropenia during chemotherapy and radiotherapy is significantly associated with the development of acute radiation-induced dysphagia in lung cancer patients. Ann Oncol 18 (2007) 909-916
10. Hirota S., Tsujino K., Endo M., et al. Dosimetric predictors of radiation esophagitis in patients treated for non-small-cell lung cancer with carboplatin/paclitaxel/radiotherapy. Int J Radiat Oncol Biol Phys 51 (2001) 291-295
11. Bradley J., Deasy J.O., Bentzen S., et al. Dosimetric correlates for acute esophagitis in patients treated with radiotherapy for lung carcinoma. Int J Radiat Oncol Biol Phys 58 (2004) 1106-1113
12. Wei Z.X., Liu H.H., Tucker S.L., et al. Risk factors for acute esophagitis in non-small-cell lung cancer patients treated with concurrent chemotherapy and three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 66 (2006) 100-107
13. Kim T.H., Cho K.H., Pyo H.R., et al. Dose-volumetric parameters of acute esophageal toxicity in patients with lung cancer treated with lung cancer treated with three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol 62 (2005) 995-1002
14. Komaki R., Swann R.S., Ettinger D.S., et al. Phase I study of thoracic radiation dose escalation with concurrent chemotherapy for patients with limited small-cell lung cancer: Report of Radiation Therapy Oncology Group (RTOG) protocol 97-12. Int J Radiat Oncol Biol Phys 62 (2005) 342-350
15. De Ruysscher D., Bremer R.-H., Koppe F., et al. Omission of elective node irradiation on basis of CT-scans in patients with limited disease small cell lung cancer: A phase II trial. Radiother Oncol 80 (2006) 307
16. Garces Y.I., Okuno S.H., Schild S.E., et al. Phase I North Central Cancer Treatment Group trial-N9923 of escalating doses of twice-daily thoracic radiation therapy with amifostine and with alternating chemotherapy in limited stage small-cell lung cancer. Int J Radiat Oncol Biol Phys 67 (2007) 995-1001
17. Movsas B., Scott C., Langer C., et al. Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: Radiation Therapy Oncology Group trial 98-01. J Clin Oncol 23 (2005) 2145-2154
18. Laurie A.S., Logan D., Markman B.R., et al. Practice guideline for the role of combination chemotherapy in the initial management of limited-stage small-cell lung cancer. Lung Cancer 43 (2004) 223-240
19. Hallqvist A., Rylander H., Bjork-Eriksson T., et al. Accelerated hyperfractionated radiotherapy and concomitant chemotherapy in small cell lung cancer limited-disease. Dose response, feasibility and outcome for patients treated in western Sweden, 1998-2004. Acta Oncol 46 (2007) 969-974